Analysts have revised their price target for NOCIL downward from ₹200.75 to ₹197.25. They cited improved profit margins and revenue growth forecasts, but noted that a lower estimated fair value and future price-to-earnings ratio contributed to the slight decrease.
What's in the News
- NOCIL Limited's Board Meeting is scheduled for October 31, 2025 at 14:30 IST (Key Developments)
- The agenda includes consideration and approval of the Un-Audited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2025 (Key Developments)
- The Board will also review the Statement of Assets and Liabilities and the Cash Flow Statement for the half year ended September 30, 2025 (Key Developments)
- Other business matters may be discussed during the meeting (Key Developments)
Valuation Changes
- Fair Value: Decreased modestly from ₹200.75 to ₹197.25
- Discount Rate: Lowered slightly from 13.52% to 13.35%
- Revenue Growth: Improved marginally from 10.69% to 11.06%
- Net Profit Margin: Increased from 8.79% to 10.31%
- Future P/E: Declined significantly from 30.86x to 25.37x
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.